Effect of carbamazepine on epilepsy with 1p36 deletion syndrome

No To Hattatsu

Volumn 39, Issue 4, 2007, Pages 289-294

  Nabatame, Shin ^a   Okinaga, Takeshi ^a   Imai, Katsumi ^a   Kamio, Noriko ^a   Kagitani Shimono, Kuriko ^a   Nagai, Toshisaburo ^a   Kurosawa, Kenji ^b   Ozono, Keiichi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KANAGAWA CHILDREN'S MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ANTICONVULSIVE AGENT; CARBAMAZEPINE; POTASSIUM CHANNEL;

ARTICLE; CASE REPORT; CHROMOSOME 1P; CHROMOSOME DELETION; CLINICAL FEATURE; DRUG EFFECT; DRUG WITHDRAWAL; EEG ABNORMALITY; EPILEPSY; FOCAL EPILEPSY; GENE MUTATION; HEART ARRHYTHMIA; HUMAN; MUSCLE SPASM; TONIC CLONIC SEIZURE; TONIC SEIZURE;

ANTICONVULSANTS; BRAIN; CARBAMAZEPINE; CHILD; CHILD, PRESCHOOL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 1; EPILEPSY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MUTATION; POTASSIUM CHANNELS, VOLTAGE-GATED; RECEPTORS, GABA-A; SYNDROME;

EID: 34547127629     PISSN: 00290831     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Hain D, Leversha M, Campbell N, Daniel A, Barr PA, Rogers JG. The ascertainment and implications of an unbalanced translocation in the neonate. Familial 1:15 translocation. Aust Paediatr J 1980;16:196-200.
2. Battaglia A. Del 1p36 syndrome: a newly emerging clinical entity. Brain Dev 2005;27:358-61.
3. Heilstedt HA, Burgess DL, Anderson AE, et al. Loss of the potassium channel beta-subunit gene, KCNAB2, is associated with epilepsy in patients with 1p36 deletion syndrome. Epilepsia 2001;42:1103-11.
4. Windpassinger C, Kroisel PM, Wagner K, Petek E. The human gamma-aminobutyric acid A receptor delta (GABRD) gene: molecular characterization and tissue-specific expression. Gene 2002;292:25-31.
5. Knight-Jones E, Knight S, Heussler H, Regan R, Flint J, Martin K. Neurodevelopmental profile of a new dysmorphic syndrome associated with submicroscopic partial deletion of 1p36.3. Dev Med Child Neurol 2000;42:201-6.
6. Horn CS, Ater SB, Hurst DL. Carbamazepine-exacerbated epilepsy in children and adolescents. Pediatr Neurol 1986:2;340-5.
7. Perucca E, Gram L, Avanzini G, Dulac O. Antiepileptic drugs as a cause of worsening seizures. Epilepsia 1998:39;5-17.
8. Shields WD, Saslow E. Myoclonic, atonic, and absence seizures following institution of carbamazepine therapy in children. Neurology 1983:33;1487-9.
9. Prats JM, Garaizar C, Garcia-Nieto ML, Madoz P. Antiepileptic drugs and atypical evolution of idiopathic partial epilepsy. Pediatr Neurol 1998:18;402-6.
10. Talwar D, Arora MS, Sher PK. EEG change and seizure exacerbation in young children treated with carbamazepine. Epilepsia 1994:35;1154-9.
11. Gobbi G, Genton P, Pini A, Livet MO. Epilepsies and chromosomal disorders. In: Roger J, Bureau M, Dravet Ch, Genton P, Tassinari CA, Wolf P, eds. Epileptic syndromes in infancy, childhood and adolescence. Montrouge: John Libbey Eurotext, 2005:467-92.
12. Pryse-Phillips WEM, Jeavons PM. Effect of carbamazepine (Tegretol) on the electroencephalograph and ward behaviour of patients with chronic epilepsy. Epilepsia 1970;11:263-73.
13. Steriade M, Dossi RC, Nunez A. Network modulation of a slow intrinsic oscillation of cat thalamocortical neurons implicated in sleep delta waves: cortically induced synchronization and brainstem cholinergic suppression. J Neurosci 1991;11:3200-17.
14. Sazgar M, Bourgeois BF. Aggravation of epilepsy by antiepileptic drugs. Pediatr Neurol 2005;33:227-34.
15. Kurosawa K, Kawame H, Okamoto N, et al. Epilepsy and neurological findings in 11 individuals with 1p36 deletion syndrome. Brain Dev 2005;27:378-82.
16. Mulley JC, Scheffer IE, Petrou S, Berkovic SF. Channelopathies as a genetic cause of epilepsy. Curr Opin Neurol 2003;16:171-6.